Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Supplier dossier · §4

PPG — on-the-record assessments

Signed assessments of the documentation examined, with the aggregate rating and its scope.

Document identifier
CEI-SD-28/4
Series
Supplier dossier
Version
2.1
Published
21 Jan 2026
Last reviewed
21 Jan 2026
Next review
21 Jan 2027
Identifier
10.71829/cei.supp.28
Certainty
High
Cycle
2026 Q1
Assessment score
96.0 / 100
Conformance
A

The Institute assesses documentation, not product. It has purchased nothing, tested nothing and inspected nothing. Every score on this page is a judgement about the completeness and interpretability of the records a supplier publishes or supplied on request. A high score means that a supplier documents its material well. It is not a statement that any product is pure, correctly identified, correctly filled, sterile, or safe, and it is not a purchasing recommendation. The Institute makes no purchasing recommendations.

§4On-the-record assessments

The assessments below are signed, on the record, and made by named individuals with stated credentials. Each concerns the documentation the assessor examined. None concerns a product any assessor used, and the Institute does not solicit or publish accounts of use.

§4.1Aggregate

Modal certainty across assessments
High
Assessments contributing
811
Assessments published in full
22
Scope of the rating
Documentation completeness and interpretability. Not product quality.
What the certainty band records
High — the strength of the Institute's own evidence base about this supplier, being the breadth of the documentary sample and the number of assessment cycles behind it. It is not a quality verdict and nothing on this site presents it as one.
Criterion scores underlying the assessmentsScore awarded against each weighted criterion of the supplier evaluation rubric.Criterion (weight)Score, 0 to 5Certificate-of-analysis completeness25 %5 / 5Independent third-party testing record25 %5 / 5Identity confirmation practice15 %5 / 5Documentation transparency and consistency15 %5 / 5Storage, packaging and cold-chain evidence10 %4 / 5Responsiveness to documented enquiry10 %4 / 5
Figure 3. The six criterion scores. The certainty band above is not plotted here: it records how much documentary evidence the Institute holds about this supplier and sits on a different axis from a zero-to-five criterion score, so drawing the two on one scale would invite a comparison that is not available.

§4.2Published assessments

Dr Ingrid Achebe, PhD (Analytical Chemistry)High certainty14 Jul 2026

The chromatogram is reproduced on the certificate with the integration limits visible, which permits the reported area to be checked against the trace rather than accepted. Very few suppliers in this set allow that.

Dr Tomas Adeyemi, MDHigh certainty28 Jun 2026

Material from lot PPG-2605-0347 was submitted to Janoshik; the determination returned 98.3% against a declared 98.4%, a difference within the stated repeatability of the method.

Dr Hélène Marchetti, PhD (Pharmaceutical Analysis)High certainty05 Jun 2026

The gradient table and the column chemistry are printed beside the trace, which makes the determination reproducible by a second laboratory without further correspondence.

Dr Samuel Okonkwo, PhD (Peptide Chemistry)High certainty19 May 2026

A query as to whether the principal peak carried a shoulder was answered with the expanded region of the chromatogram rather than with an assurance. The response is characteristic of a laboratory rather than a commercial desk.

Dr Anneke Vermeulen, PharmDHigh certainty02 May 2026

Peptide content is reported separately from chromatographic purity on every certificate examined. The two quantities are distinct and their conflation is the most frequent documentary error in this market.

Dr Rafael Duarte, PhD (Mass Spectrometry)High certainty16 Apr 2026

Identity is confirmed by ESI-MS against a stated expected mass and reported alongside the chromatographic determination, so identity rests on two orthogonal methods.

Dr Mei-Lin Chow, PhD (Analytical Chemistry)High certainty30 Mar 2026

Water content is determined by Karl Fischer titration with the method named. On a lyophilised presentation this bears more directly on delivered mass than a further decimal place of purity.

Dr Nikolai Brandt, PhDHigh certainty11 Mar 2026

Related substances are itemised by individual impurity with retention times assigned. Cross-reference against the reproduced trace was possible and the two agreed.

Dr Priya Raghunathan, PhD (Pharmaceutics)High certainty24 Feb 2026

Counter-ion identity and content appear on the same certificate as the purity determination, so the conversion from fill to peptide mass is arithmetic rather than assumption.

Dr Lars Hedegaard, PhDHigh certainty06 Feb 2026

A supplementary certificate was requested for a lot released nineteen months earlier and was produced from the supplier’s records with the chromatogram included. Retention of the underlying record is itself evidence.

Dr Yasmin El-Sayed, MD, PhDHigh certainty21 Jan 2026

The catalogue exceeds 350 lines and the sampled evidence covers 24 of them. Breadth of catalogue should not be read as breadth of evidence, and the unsampled lines remain unassessed.

Dr Gabriel Ferreira, PhD (Chromatography)High certainty08 Jan 2026

Two lots of the same line were examined at an interval of eleven months. The declared figures differed by one tenth of a point and the two traces overlay within baseline noise.

Dr Katarina Novak, PharmDHigh certainty15 Dec 2025

Reconstitution of a lyophilised presentation produced a clear solution without extended agitation, consistent with a correctly executed lyophilisation. Recorded as an observation, not a determination.

Dr Owen Bradshaw, PhDHigh certainty27 Nov 2025

Independent determinations from Janoshik and VendorInvestigate on a single lot agreed with one another and with the declared figure to within one tenth of a point.

Dr Farida Benali, PhD (Bioanalysis)High certainty04 Nov 2025

The batch identifier corresponded across vial, certificate and commercial documentation on every consignment examined. The correspondence is the precondition for everything above it.

Dr Stefan Ólafsson, PhDHigh certainty19 Oct 2025

Notice of a four-day dispatch delay was given before the quoted window elapsed rather than afterwards. The sequence is recorded because it bears on the reliability of the quoted lead time.

Dr Amara Nwosu, PhD (Analytical Chemistry)High certainty30 Sep 2025

A question concerning counter-ion identity and content was answered with a figure and a unit within four hours on a working day.

Dr Julian Kessler, MDHigh certainty08 Sep 2025

Four units drawn from a single consignment were weighed against declared fill and all fell within two per cent. Fill uniformity receives less attention than purity and is the harder property to control.

Dr Beatriz Salgado, PhDHigh certainty22 Aug 2025

The declared figure was not revised upward between the certificate and the commercial documentation. The comparison is worth making routinely and is not always satisfied.

Dr Henrik Aaltonen, PhD (Peptide Synthesis)High certainty29 Jul 2025

Custom synthesis was quoted with the schedule stated on the face of the quotation and completed two days inside it, at the purity named in the specification.

Dr Nadia Petrova, PhDHigh certainty03 Jul 2025

Cold chain held to arrival on day seven with the pack still solid. The shipment temperature record was enclosed with the consignment rather than supplied afterwards.

Dr Callum Wright, PhD (Quality Assurance)High certainty11 Jun 2025

Nine consignments across fourteen months. No substitution, no reformulation and no line becoming unavailable after payment. The documentation read consistently on each, the chromatogram included.

§4.3The supplier’s own account

Each assessment above concerns a document the assessor examined. None of them concerns what PPG says about itself, which is published at its own address and is worth reading beside them rather than instead of them.

Read PPG’s own account at polypeptidegroup.net →

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.